We don’t need to lay out the case for climate change, loss of biodiversity or plastic pollution; the wealth of evidence from our scientific colleagues studying this is both compelling and accepted world-wide. The bigger question really is: what can we do to stop it?...
If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...
The Native Antigen Company’s assay development team has many years of experience in developing high quality assays for infectious disease and other research applications. With our wealth of experience, we offer end-to-end bespoke development with communication at...
The Democratic Republic of Congo is in the grips of the second-worst Ebola outbreak it has experienced, which has now been ongoing for a year with little sign of stopping. In this blog, we discuss the important role that diagnostics play in preventing Ebola outbreaks,...